Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07523LS in Newborn Infants Exposed to HIV-1.
Cunningham CK, McFarland EJ, Muresan P, Capparelli EV, Perlowski C, Johnston B, Bone F, Purdue L, Yin DE, Moye J, Spiegel HML, Majji S, Theron GB, Mujuru HA, Purswani M, Alvarez G, Deville JG, Chambers C, Brown E, Harding PA, Tobin NH, Low K, Gama L; IMPAACT P1112 team.
Cunningham CK, et al. Among authors: yin de.
J Pediatric Infect Dis Soc. 2025 Jan 16:piaf002. doi: 10.1093/jpids/piaf002. Online ahead of print.
J Pediatric Infect Dis Soc. 2025.
PMID: 39821046